BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11890979)

  • 1. Transcranial magnetic stimulation and Parkinson's disease.
    Cantello R; Tarletti R; Civardi C
    Brain Res Brain Res Rev; 2002 Feb; 38(3):309-27. PubMed ID: 11890979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
    Lefaucheur JP
    Clin Neurophysiol; 2005 Feb; 116(2):244-53. PubMed ID: 15661100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Motor cortex stimulation for Parkinson's disease and dystonia: lessons from transcranial magnetic stimulation? A review of the literature].
    Lefaucheur JP
    Rev Neurol (Paris); 2005 Jan; 161(1):27-41. PubMed ID: 15677999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease.
    Rothwell JC; Edwards MJ
    Handb Clin Neurol; 2013; 116():535-42. PubMed ID: 24112921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor cortical circuits in Parkinson disease and dystonia.
    Udupa K; Chen R
    Handb Clin Neurol; 2019; 161():167-186. PubMed ID: 31307598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triad-conditioning transcranial magnetic stimulation in Parkinson's disease.
    Hanajima R; Terao Y; Shirota Y; Ohminami S; Tsutsumi R; Shimizu T; Tanaka N; Okabe S; Tsuji S; Ugawa Y
    Brain Stimul; 2014; 7(1):74-9. PubMed ID: 24183477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying mirror movements in Parkinson's disease: a transcranial magnetic stimulation study.
    Cincotta M; Borgheresi A; Balestrieri F; Giovannelli F; Ragazzoni A; Vanni P; Benvenuti F; Zaccara G; Ziemann U
    Mov Disord; 2006 Jul; 21(7):1019-25. PubMed ID: 16547917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired motor cortical inhibition in Parkinson's disease: motor unit responses to transcranial magnetic stimulation.
    Kleine BU; Praamstra P; Stegeman DF; Zwarts MJ
    Exp Brain Res; 2001 Jun; 138(4):477-83. PubMed ID: 11465746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaco-transcranial magnetic stimulation studies of motor excitability.
    Ziemann U
    Handb Clin Neurol; 2013; 116():387-97. PubMed ID: 24112911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resetting tremor by single and paired transcranial magnetic stimulation in Parkinson's disease and essential tremor.
    Lu MK; Chiou SM; Ziemann U; Huang HC; Yang YW; Tsai CH
    Clin Neurophysiol; 2015 Dec; 126(12):2330-6. PubMed ID: 25792076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in motor cortex excitability associated with muscle fatigue in patients with Parkinson's disease.
    Milanović S; Filipović SR; Radovanović S; Blesić S; Ilić NV; Kostić VS; Ljubisavljević MR
    Vojnosanit Pregl; 2013 Mar; 70(3):298-303. PubMed ID: 23607242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic and therapeutic application of transcranial magnetic stimulation].
    Derejko M; Niewiadomska M; Rakowicz M
    Neurol Neurochir Pol; 2005; 39(5):389-96. PubMed ID: 16273463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
    Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-hand water flow stimulation increases motor cortical excitability: a study of transcranial magnetic stimulation and movement-related cortical potentials.
    Sato D; Yamashiro K; Onishi H; Yasuhiro B; Shimoyama Y; Maruyama A
    J Neurophysiol; 2015 Feb; 113(3):822-33. PubMed ID: 25376780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients.
    Ponzo V; Di Lorenzo F; Brusa L; Schirinzi T; Battistini S; Ricci C; Sambucci M; Caltagirone C; Koch G
    Mov Disord; 2017 May; 32(5):750-756. PubMed ID: 28186666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cortical excitability profile of patients with the G209A SNCA mutation versus patients with sporadic Parkinson's disease: A transcranial magnetic stimulation study.
    Kimiskidis VK; Papayiannopoulos S; Sotirakoglou K; Karakasis H; Katsarou Z; Kazis DA; Papaliagkas V; Gatzonis S; Papadimitriou A; Hadjigeorgiou G; Bostanjopoulou S
    Neurophysiol Clin; 2018 Sep; 48(4):203-206. PubMed ID: 29729894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal conditioning effect of transcranial magnetic stimulation on soleus H-reflex during voluntary movement in Parkinson's disease.
    Morita H; Shindo M; Morita S; Hashimoto T; Tada T; Ikeda S
    Clin Neurophysiol; 2002 Aug; 113(8):1316-24. PubMed ID: 12140013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease.
    Kačar A; Filipović SR; Kresojević N; Milanović SD; Ljubisavljević M; Kostić VS; Rothwell JC
    Clin Neurophysiol; 2013 Apr; 124(4):697-707. PubMed ID: 23085389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.